American Century Companies’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
Other funds holding KROS
NCM
O
MAP
American Century Companies's KROS Position: Q2 2026 in Review
American Century Companies increased its Keros Therapeutics (KROS) stake by 32% in Q2 2026, buying an estimated $227K and bringing the position to 84,680 shares worth $906K. The position accounts for ﹤0.01% of the portfolio, ranked #2425.
American Century Companies first reported a position in KROS in Q1 2023 and has held it in 12 quarters since. The position peaked at $17.3M in Q3 2024. 132 funds tracked by Wall St. Rank hold KROS as of Q2 2026.
- American Century Companies held 84,680 shares of Keros Therapeutics worth $906K as of Q2 2026.
- American Century Companies bought 20,420 Keros Therapeutics shares in Q2 2026, an estimated $227K.
- Keros Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2425 holding.
- American Century Companies first reported a position in Keros Therapeutics in Q1 2023 and has held it in 12 quarters since.
- American Century Companies's Keros Therapeutics position peaked at $17.3M in Q3 2024.
- 132 funds tracked by Wall St. Rank held Keros Therapeutics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.